Panacea Biotec Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹548.85
Market cap
3,364 Cr
P/B
4.06

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales129 Cr272 Cr423 Cr559 Cr116 Cr263 Cr163 Cr133 Cr167 Cr141 Cr165 Cr167 Cr
Operating expenses (approx.)106 Cr246 Cr388 Cr517 Cr123 Cr256 Cr149 Cr123 Cr151 Cr150 Cr148 Cr159 Cr
EBITDA24 Cr26 Cr34 Cr42 Cr-7 Cr7 Cr14 Cr9 Cr16 Cr-9 Cr17 Cr8 Cr
OPM %18.2%9.5%8.1%7.5%-6.4%2.6%8.8%7.1%9.5%-6.2%10.2%4.7%
Other income6 Cr9 Cr15 Cr26 Cr4 Cr8 Cr4 Cr9 Cr6 Cr6 Cr2 Cr3 Cr
Interest1 Cr2 Cr3 Cr4 Cr0.87 Cr2 Cr0.99 Cr1 Cr0.86 Cr2 Cr2 Cr1 Cr
Depreciation9 Cr19 Cr28 Cr37 Cr9 Cr17 Cr9 Cr8 Cr8 Cr8 Cr8 Cr8 Cr
Profit before tax13 Cr5 Cr4 Cr1 Cr-17 Cr-12 Cr4 Cr-0.04 Cr7 Cr-19 Cr6 Cr-1 Cr
Tax %15.7%48.8%86.4%201.4%6.9%9.1%-1.4%-4875.0%39.6%26.9%40.1%20.0%
Net profit11 Cr3 Cr0.49 Cr-1 Cr-16 Cr-11 Cr4 Cr-2 Cr4 Cr-14 Cr4 Cr-1 Cr
EPS (₹)₹1.79₹0.44₹0.04₹-0.19₹-2.59₹-1.80₹0.74₹-0.31₹0.66₹-2.27₹0.65₹0.08

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2020Mar 2021Mar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales544 Cr625 Cr661 Cr460 Cr559 Cr559 Cr640 CrSign in for TTM
Operating expenses (approx.)498 Cr538 Cr-1,012 Cr455 Cr543 Cr528 Cr608 CrSign in for TTM
EBITDA46 Cr87 Cr1,673 Cr5 Cr16 Cr31 Cr32 CrSign in for TTM
OPM %8.4%13.9%253.1%1.0%2.9%5.5%5.0%Sign in for TTM
Other income30 Cr10 Cr11 Cr52 Cr26 Cr21 Cr17 CrSign in for TTM
Interest174 Cr185 Cr181 Cr4 Cr4 Cr4 Cr6 CrSign in for TTM
Depreciation43 Cr46 Cr44 Cr39 Cr37 Cr35 Cr33 CrSign in for TTM
Profit before tax-172 Cr-144 Cr1,449 Cr13 Cr1 Cr-8 Cr-7 CrSign in for TTM
Tax %-9.7%-1.4%25.6%363.7%201.4%-9.7%2.8%Sign in for TTM
Net profit-194 Cr-148 Cr1,078 Cr-34 Cr-1 Cr-9 Cr-7 CrSign in for TTM
EPS (₹)₹-31.72₹-24.11₹175.98₹-5.51₹-0.19₹-1.37₹-0.88Sign in for TTM
Dividend payout %——0.0%————Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2020Mar 2021Mar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Equity capital6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr
Reserves171 Cr-276 Cr843 Cr837 Cr836 Cr829 Cr829 Cr
Borrowings——84 Cr20 Cr21 Cr——
Other liabilities890 Cr1,412 Cr263 Cr411 Cr381 Cr459 Cr433 Cr
Total liabilities1,067 Cr1,142 Cr762 Cr1,265 Cr1,241 Cr1,290 Cr1,262 Cr
Fixed assets (net)——416 Cr588 Cr560 Cr543 Cr553 Cr
CWIP——0.86 Cr28 Cr75 Cr94 Cr100 Cr
Investments——0.27 Cr13 Cr40 Cr3 Cr10 Cr
Other assets——250 Cr564 Cr488 Cr548 Cr515 Cr
Total assets1,067 Cr1,142 Cr762 Cr1,265 Cr1,241 Cr1,290 Cr1,262 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2020Mar 2021Mar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity——-108 Cr-423 Cr-0.10 Cr-27 Cr17 Cr
Cash from investing——1,283 Cr430 Cr10 Cr65 Cr-40 Cr
Cash from financing——-1,176 Cr-18 Cr-3 Cr-3 Cr-1 Cr
Net cash flow——-2 Cr-12 Cr7 Cr35 Cr-25 Cr
Free cash flow (OCF − Capex)——-121 Cr-464 Cr-78 Cr-78 Cr-37 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2020Mar 2021Mar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
ROCE %1.4%—192.0%-4.0%-2.4%-0.5%-0.2%
ROE %-109.8%—127.0%0.0%-0.1%-1.0%-0.6%
Debtor days——364837——
Inventory days——273349309363242
Days payable——356306267——
Cash conversion cycle——-479080363242
Debt / equity——0.200.020.03——
Current ratio——1.021.711.571.491.47
Net debt / EBITDA0.000.000.00-4.18-1.64-2.67-1.81

Compare with peers

Loading peers…